Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Ointments: SOP for Managing Retained Samples and Associated Records – V 2.0

Posted on By

SOP for Managing Retained Samples and Associated Records – V 2.0

Procedure for Managing Retained Samples and Associated Records

Department Quality Assurance (QA)/Quality Control (QC)/Warehouse
SOP No. SOP/Ointment/168
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a structured approach for the storage, handling, and documentation of retained samples in pharmaceutical manufacturing. Retained samples serve as reference materials to verify batch quality, support investigations, and meet regulatory compliance requirements.

2. Scope

This SOP applies to all retained samples of raw materials, packaging materials, in-process materials, and finished pharmaceutical products. It covers personnel in Quality Assurance (QA), Quality Control (QC), and Warehouse departments involved in sample storage, retrieval, and record management.

3. Responsibilities

  • QC Analyst: Collects and labels retained samples.
  • QA Officer: Ensures proper storage conditions and record-keeping.
  • Warehouse Supervisor: Monitors environmental conditions of retained sample storage areas.
  • QA Manager: Reviews and approves retained sample documentation.
See also  Ointments: SOP for Documentation of Formulation Development Process - V 2.0

4. Accountability

The QA Manager is accountable for ensuring that all retained samples and associated records comply with GMP, FDA, ICH, and WHO guidelines.

5. Procedure

5.1 Selection and Collection of Retained Samples

Retained samples must be collected from each batch as per regulatory requirements:

  • Raw materials: **Minimum 2X the amount required for full analysis**.
  • Packaging materials: **At
least one complete set per batch**.
  • Finished products: **Twice the quantity required for testing**.
  • In-process samples: **As required by process validation protocols**.
  • Each sample must be labeled with:

    • Product or material name
    • Batch number
    • Manufacturing date
    • Expiry date
    • Sample storage conditions

    5.2 Storage Conditions for Retained Samples

    • Retained samples must be stored in **designated, locked cabinets or rooms**.
    • Storage conditions must comply with product-specific temperature and humidity requirements:
      • Controlled Room Temperature: **15-25°C**
      • Refrigerated Products: **2-8°C**
      • Freezer Storage: **-20°C or lower**
    • Storage areas must be **monitored daily** using calibrated temperature and humidity monitoring devices.
    • Samples must be arranged in a **First In, First Out (FIFO)** manner.

    5.3 Documentation of Retained Samples

    • Each retained sample must be logged in the **Retained Sample Register (Annexure-1).**
    • Sample records must include:
      • Batch number and sample code
      • Collection date and expiry date
      • Storage location
      • Authorized personnel signatures
    • Electronic records must be stored in a **validated Document Management System (DMS).**

    5.4 Periodic Review and Disposal of Retained Samples

    • QA must conduct a **quarterly review** of retained samples.
    • Retained samples must be stored for a period of **at least one year after product expiry.**
    • Expired samples must be **disposed of following a controlled destruction process** and documented in the **Sample Destruction Log (Annexure-2).**
    • Destruction must be performed under QA supervision and approved by the QA Manager.

    5.5 Retrieval of Retained Samples

    • Retained samples may only be retrieved for:
      • Regulatory inspections
      • Market complaint investigations
      • Product recalls
      • Internal quality assessments
    • All retrievals must be documented in the **Retained Sample Issuance Log.**
    • Samples must not be returned to storage once removed.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • DMS – Document Management System
    • FIFO – First In, First Out
    • FDA – Food and Drug Administration
    • ICH – International Council for Harmonisation

    7. Documents

    • Retained Sample Register (Annexure-1)
    • Sample Destruction Log (Annexure-2)

    8. References

    • ICH Q7 – GMP for Active Pharmaceutical Ingredients
    • WHO Guidelines on Retained Samples
    • US FDA Guidance on Stability and Retention of Samples

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Retained Sample Register

    Date Batch No. Sample Code Storage Location QA Approval
    02/02/2025 OINT-1001 RS-001 Room Temp Approved

    Annexure-2: Sample Destruction Log

    Date Sample Code Batch No. Destruction Method QA Approval
    02/02/2030 RS-001 OINT-1001 Incineration Approved

    12. Revision History

    Revision Date Revision No. Details Reason Approved By
    02/02/2025 2.0 Expanded Retained Sample Storage Procedures Improved Compliance QA Head
    See also  Ointments: SOP for Ensuring Compliance with Utility Validation Standards - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Capsule: SOP for Cleaning Gelatin Feeders in Capsule Manufacturing – V 2.0
    Next Post: SOP for Final Quality Inspection of Medical Devices

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version